BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31028202)

  • 1. Combined EGFR/ALK Expression Analysis in Laryngeal Squamous Cell Carcinoma.
    Politi A; Tsiambas E; Mastronikolis NS; Peschos D; Asproudis I; Kyrodimos E; Armata IE; Chrysovergis A; Asimakopoulos A; Papanikolaou VS; Batistatou A; Ragos V
    In Vivo; 2019; 33(3):815-819. PubMed ID: 31028202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous over activation of EGFR, telomerase (h TERT), and cyclin D1 correlates with advanced disease in larynx squamous cell carcinoma: a tissue microarray analysis.
    Chrysovergis A; Gorgoulis VG; Giotakis I; Tsiambas E; Karameris A; Kittas C; Kyroudi A
    Med Oncol; 2011 Sep; 28(3):871-7. PubMed ID: 20373052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma.
    Vivatvakin S; Ratchataswan T; Leesutipornchai T; Ruangritchankul K; Keelawat S; Mahattanasakul P; Bongsebandhu-Phubhakdi S
    Sci Rep; 2021 Jul; 11(1):14607. PubMed ID: 34272446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laryngeal carcinoma lymph node metastasis and disease-free survival correlate with MASPIN nuclear expression but not with EGFR expression: a series of 108 cases.
    Marioni G; Staffieri A; Bertolin A; Giacomelli L; D'Alessandro E; Ottaviano G; Accordi D; Stramare R; de Filippis C; Blandamura S
    Eur Arch Otorhinolaryngol; 2010 Jul; 267(7):1103-10. PubMed ID: 20052590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of ALK-positive pulmonary squamous-cell carcinoma: From diagnostic methodologies to clinical efficacy.
    Wang H; Sun L; Sang Y; Yang X; Tian G; Wang Z; Fang J; Sun W; Zhou L; Jia L; Tsao MS; Shi H; Lin D
    Lung Cancer; 2019 Apr; 130():135-142. PubMed ID: 30885334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study.
    Liang H; Song X; Zhang Y; Zhang S; Li F; Fang J; Li J; Liang L; Nie L; Ma K; Zhang L; Wang X; Xu J; Wei Y; Wang J; Song Q; Tian G; Mu Y; Gu Y; Yang L; Sun P; Zhong W; Zhao J; Xu Y; Chen M; Wang M
    Thorac Cancer; 2019 Jul; 10(7):1521-1532. PubMed ID: 31144459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoid X receptor overexpression desensitizes laryngeal epithelium to carcinogenic effects associated with epidermal growth factor receptor upregulation.
    Kourelis K; Vandoros G; Kourelis T; Goumas P; Sotiropoulou-Bonikou G
    J Otolaryngol Head Neck Surg; 2009 Apr; 38(2):233-9. PubMed ID: 19442374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased ALK gene copy number and amplification are frequent in non-small cell lung cancer.
    Salido M; Pijuan L; Martínez-Avilés L; Galván AB; Cañadas I; Rovira A; Zanui M; Martínez A; Longarón R; Sole F; Serrano S; Bellosillo B; Wynes MW; Albanell J; Hirsch FR; Arriola E
    J Thorac Oncol; 2011 Jan; 6(1):21-7. PubMed ID: 21107285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA ZNF609 promotes laryngeal squamous cell carcinoma progression by upregulating epidermal growth factor receptor via sponging microRNA-134-5p.
    Yin X; Wang J; Shan C; Jia Q; Bian Y; Zhang H
    Bioengineered; 2022 Mar; 13(3):6929-6941. PubMed ID: 35236250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc finger protein x-linked (ZFX) contributes to patient prognosis, cell proliferation and apoptosis in human laryngeal squamous cell carcinoma.
    Yang F; Ma H; Feng L; Lian M; Wang R; Fan E; Fang J
    Int J Clin Exp Pathol; 2015; 8(11):13886-99. PubMed ID: 26823701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-targeting ALK and EGFR parallel signaling in oral squamous cell carcinoma.
    Gonzales CB; De La Chapa JJ; Saikumar P; Singha PK; Dybdal-Hargreaves NF; Chavez J; Horning AM; Parra J; Kirma NB
    Oral Oncol; 2016 Aug; 59():12-19. PubMed ID: 27424178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor mutations in Chinese patients with laryngeal squamous cell carcinoma.
    Wang DS; Lai HC; Huang JM
    Acta Otolaryngol; 2014 Jun; 134(6):631-5. PubMed ID: 24646139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 Gene Numerical Imbalances in Laryngeal Squamous Cell Carcinoma: A Tissue Microarray Grid Based Analysis.
    Kyrodimos E; Papanikolaou V; Tsiambas E; Kikidis D; Peschos D; Ragos V; Mastronikolis N; Riziotis C; Chrysovergis A
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):379-384. PubMed ID: 32102514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EGFR-mTOR pathway and laryngeal cancer angiogenesis.
    Lionello M; Lovato A; Staffieri A; Blandamura S; Turato C; Giacomelli L; Staffieri C; Marioni G
    Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):757-64. PubMed ID: 24065188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression patterns of the HER4 receptors in normal mucosa and in laryngeal squamous cell carcinomas: antioncogenic significance of the HER4 protein in laryngeal squamous cell carcinoma.
    Bussu F; Ranelletti FO; Gessi M; Graziani C; Lanza P; Lauriola L; Paludetti G; Almadori G
    Laryngoscope; 2012 Aug; 122(8):1724-33. PubMed ID: 22549618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of EGFR, cerbB2, p16, and p53 and their relationship with conventional parameters in squamous cell carcinoma of the larynx.
    Şimşek H; Han Ü; Önal B; Şimişek G
    Turk J Med Sci; 2014; 44(3):411-6. PubMed ID: 25558642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of UHRF1 is significantly associated with poor prognosis in laryngeal squamous cell carcinoma.
    Pi JT; Lin Y; Quan Q; Chen LL; Jiang LZ; Chi W; Chen HY
    Med Oncol; 2013 Dec; 30(4):613. PubMed ID: 24005809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of astrocyte elevated gene-1 protein and its clinical significance in laryngeal squamous cell carcinoma].
    Liu Y; Li G; Su ZW; Qiu YZ; Zhang X; Yu CY; Zhou XJ; Ren SL; Huang DH; Tian YQ
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):111-5. PubMed ID: 23710918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular detection and clinical significance of ALK rearrangement in selected advanced non-small cell lung cancer: ALK expression provides insights into ALK targeted therapy.
    Zhang NN; Liu YT; Ma L; Wang L; Hao XZ; Yuan Z; Lin DM; Li D; Zhou YJ; Lin H; Han XH; Sun Y; Shi Y
    PLoS One; 2014; 9(1):e84501. PubMed ID: 24404167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma.
    Yin K; Feng HB; Li LL; Chen Y; Xie Z; Lv ZY; Guo WB; Lu DX; Yang XN; Yan WQ; Wu YL; Zhang XC
    Thorac Cancer; 2020 Feb; 11(2):346-352. PubMed ID: 31794146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.